BCMAp: an integral membrane protein in the Golgi apparatus of human mature B lymphocytes
Related Experiment Video
Updated: Aug 8, 2026

The Cell-based L-Glutathione Protection Assays to Study Endocytosis and Recycling of Plasma Membrane Proteins
Published on: December 13, 2013
M P Gras1, Y Laâbi, G Linares-Cruz
1INSERM U 301, Institut de Génétique Moléculaire, Paris, France.
Insights
B-cell maturation antigen (BCMA) is a Golgi-resident protein specific to B lymphocytes. Its expression increases with B-cell differentiation, suggesting a role in immunoglobulin intracellular traffic.
Area of Science:
- Molecular Biology
- Cell Biology
- Immunology
Background:
- B-cell maturation antigen (BCMA) is a gene expressed in mature B lymphocytes.
- BCMA encodes a peptide (BCMAp) that is an integral membrane protein.
Purpose of the Study:
- To investigate BCMA mRNA expression during B lymphocyte differentiation.
- To determine the localization and function of BCMAp.
Main Methods:
- Analysis of BCMA mRNA in human malignant B cell lines.
- Cellular fractionation and immunoprecipitation using polyclonal antibodies.
- Immunofluorescence and confocal microscopy to identify BCMAp localization.
Main Results:
- BCMA mRNA expression is absent in pro-B cells, faint in pre-B cells, and increases with B-cell maturation.
- BCMAp is a non-glycosylated type I integral membrane protein.
- BCMAp localizes to the cis-Golgi apparatus, not the plasma membrane.
Conclusions:
- BCMAp is the first identified Golgi-resident protein with tissue specificity and differentiation-linked expression in B lymphocytes.
- BCMAp's localization suggests involvement in the intracellular trafficking of immunoglobulins.
Abstract:
BCMA is a human gene expressed preferentially in mature B lymphocytes as a 1.2 kb mRNA, which encodes a 184 amino acid peptide (BCMAp). The study of BCMA mRNA expression, using human malignant B cell lines characteristic of different stages of B lymphocyte differentiation, demonstrated that the BCMA mRNA is absent in the pro-B lymphocyte stage. It is expressed faintly at the pre-B cell stage and its expression increases with B lymphocyte maturation. Polyclonal antibodies were used to show, by cellular fractionation and immunoprecipitation, that BCMAp is a non-glycosylated integral membrane protein. Furthermore, BCMAp inserts, in vitro, into canine microsomes, as a type I integral membrane protein. Cell surface labeling showed that BCMAp is not expressed in the plasma membrane of mature B lymphocytes. Immunofluorescence studies revealed that BCMAp lies in a cap-like structure near the nucleus, that was identified as the Golgi apparatus by co-localization of BCMAp with CTR433, a marker of the medial cisternae of the Golgi apparatus. Confocal scanning laser microscopy of U266 plasma cells labeled with markers of various Golgi apparatus subcompartments strongly suggests that BCMAp is located in the cis part of the Golgi apparatus. Thus, BCMAp is the first Golgi resident protein with a tissue specificity and whose expression is linked to the stage of differentiation of B lymphocytes. The location of BCMAp in the Golgi apparatus and its high expression in plasmocytes (secreting large amounts of Ig) suggest that BCMAp is implicated in the intracellular traffic of Ig.
More Related Videos
Related Concept Videos
Coat Assembly and GTPases
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
Golgi Matrix Proteins
One of the first identified Golgi matrix proteins was GM130, a rod-like protein located in the cis-Golgi. Subsequently, many Golgi...
Transport Across the Golgi
Differentiation of Common Myeloid Progenitor Cells
Rab Cascades
IP3/DAG Signaling Pathway

